Tandem Diabetes Care, Inc. Payments for Leasing Costs, Commissions, and Tenant Improvements
Tandem Diabetes Care, Inc. (TNDM) reported Payments for Leasing Costs, Commissions, and Tenant Improvements of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-24.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForLeasingCostsCommissionsAndTenantImprovements · last filed 2020-02-24
- Tandem Diabetes Care, Inc. payments for leasing costs, commissions, and tenant improvements for the quarter ending 2017-12-31 was $255.00K.
- Tandem Diabetes Care, Inc. payments for leasing costs, commissions, and tenant improvements for the quarter ending 2017-09-30 was $253.00K.
- Tandem Diabetes Care, Inc. payments for leasing costs, commissions, and tenant improvements for the quarter ending 2017-06-30 was $1.01M.
- Tandem Diabetes Care, Inc. payments for leasing costs, commissions, and tenant improvements for the quarter ending 2017-03-31 was $1.77M.
- Tandem Diabetes Care, Inc. payments for leasing costs, commissions, and tenant improvements for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- Tandem Diabetes Care, Inc. payments for leasing costs, commissions, and tenant improvements for fiscal 2018 was $13.00K, a 99.61% decline from fiscal 2017.
- Tandem Diabetes Care, Inc. payments for leasing costs, commissions, and tenant improvements for fiscal 2017 was $3.29M.
- Tandem Diabetes Care, Inc. payments for leasing costs, commissions, and tenant improvements for fiscal 2015 was $933.00K, a 41.83% decline from fiscal 2014.
| Period end | Payments for Leasing Costs, Commissions, and Tenant Improvements 3 month | Payments for Leasing Costs, Commissions, and Tenant Improvements 6 month | Payments for Leasing Costs, Commissions, and Tenant Improvements 9 month | Payments for Leasing Costs, Commissions, and Tenant Improvements 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-02-24 | |||
| 2018-12-31 | $13.00K 10-K · filed 2020-02-24 | |||
| 2017-12-31 | $255.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $508.00K derived: sum of 2 quarters · filed 2020-02-24 | $1.52M derived: sum of 3 quarters · filed 2020-02-24 | $3.29M 10-K · filed 2020-02-24 |
| 2017-09-30 | $253.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $1.26M derived: sum of 2 quarters · filed 2018-11-01 | $3.04M 10-Q · filed 2018-11-01 | |
| 2017-06-30 | $1.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-30 | $2.78M 10-Q · filed 2018-07-30 | ||
| 2017-03-31 | $1.77M 10-Q · filed 2018-04-26 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $0.00 derived: sum of 2 quarters · filed 2018-03-01 | $933.00K 10-K · filed 2018-03-01 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | $933.00K 10-Q · filed 2016-11-01 | ||
| 2015-06-30 | $933.00K 10-Q · filed 2016-07-28 | |||
| 2014-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-08 | $4.00K derived: sum of 2 quarters · filed 2017-03-08 | $1.60M 10-K · filed 2017-03-08 | |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | $1.60M 10-Q · filed 2015-10-29 | ||
| 2014-06-30 | $1.60M 10-Q · filed 2015-07-30 | |||
| 2012-12-31 | $2.02M 10-K · filed 2015-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |